Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.

At present, the etiology of Alzheimer's disease (AD) is still unclear, but both genetic and non-genetic factors are thought to take part in the etiopathogenesis of AD. Epidemiologic researches revealed that genetic factors played a decisive role in the development of both early-onset AD (EOAD) and late-onset AD (LOAD). The mutations in APP, PSEN1 and PSEN2 are inherited in a Mendelian fashion and directly lead to the EOAD, while recent genome-wide association studies have identified numbers of risky genes, which influences the susceptibility to LOAD. Although genetic factors are inherited and fixed, non-genetic factors, such as occupational exposures (exposure to pesticides, electromagnetic fields, organic solvents and volatile anesthetics), pre-existing medical conditions (cerebrovascular disease, hypertension, diabetes, dyslipidemia, traumatic brain injury, depression and cancer) and lifestyle factors (smoking, consumptions of alcohol and coffee, body mass index, physical activity and cognitive activity), are partly environmentally-determined. Timely interventions targeted at these non-genetic risk factors may offer opportunities for prevention and treatment of AD. In the future, more high-quality and large-sample epidemiologic studies are needed to identify risk factors for AD, and the interaction models between genetic and non-genetic risk factors required further investigation. In addition, public health campaigns targeted at modification of non-genetic risk factors should be developed among population at high risk of AD.

[1]  C. Rowe,et al.  Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing , 2013, Molecular Psychiatry.

[2]  L. Calvó-Perxas,et al.  Depression subtypes and 5‐year risk of dementia and Alzheimer disease in patients aged 70 years , 2013, International journal of geriatric psychiatry.

[3]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[4]  F. Thinnes Why cancer survivors have a lower risk of Alzheimer disease. , 2012, Molecular genetics and metabolism.

[5]  D. Perl,et al.  Dementia resulting from traumatic brain injury: what is the pathology? , 2012, Archives of neurology.

[6]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[7]  N. Zawia,et al.  Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. , 2012, Current Alzheimer research.

[8]  G. Schellenberg,et al.  The genetics and neuropathology of Alzheimer’s disease , 2012, Acta Neuropathologica.

[9]  V. Kyriazopoulou,et al.  Ghrelin and leptin secretion in patients with moderate Alzheimer’s disease , 2012, The journal of nutrition, health & aging.

[10]  E. Marcantonio,et al.  Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory , 2012, Annals of neurology.

[11]  K. Yaffe,et al.  Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. , 2012, Archives of general psychiatry.

[12]  W. Jagust,et al.  Association of lifetime cognitive engagement and low β-amyloid deposition. , 2012, Archives of neurology.

[13]  D A Bennett,et al.  Total daily physical activity and the risk of AD and cognitive decline in older adults , 2012, Neurology.

[14]  L. Buée,et al.  Tau Phosphorylation and Sevoflurane Anesthesia: An Association to Postoperative Cognitive Impairment , 2012, Anesthesiology.

[15]  J. Schröder,et al.  Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease , 2012, Psychiatry Research.

[16]  Sudha Seshadri,et al.  Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study , 2012, BMJ : British Medical Journal.

[17]  C. McCollum,et al.  Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia. , 2012, The American journal of psychiatry.

[18]  V. Haroutunian,et al.  Hypertension is associated with cognitive decline in elderly people at high risk for dementia. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  Luc Verschaeve,et al.  Can cytogenetics explain the possible association between exposure to extreme low‐frequency magnetic fields and Alzheimer's disease? , 2012, Journal of applied toxicology : JAT.

[20]  A. Brickman,et al.  Memory after silent stroke , 2012, Neurology.

[21]  J. Beyene,et al.  Exposure to general anesthesia and risk of alzheimer's disease: a systematic review and meta-analysis , 2011, BMC geriatrics.

[22]  Zheng-rong Wang,et al.  The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta‐analysis of longitudinal studies , 2011, International journal of clinical practice.

[23]  R. Honea,et al.  Alzheimer disease biomarkers are associated with body mass index , 2011, Neurology.

[24]  L. Launer,et al.  Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy Study , 2011, Annals of neurology.

[25]  H. Hanyu,et al.  Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease , 2011, Neurobiology of Aging.

[26]  M. Sano,et al.  A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease , 2011, Neurology.

[27]  L. Launer,et al.  White Matter Lesions on Brain Magnetic Resonance Imaging Scan and 5‐Year Cognitive Decline: The Honolulu‐Asia Aging Study , 2011, Journal of the American Geriatrics Society.

[28]  Huadong Zhou,et al.  Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease. , 2011, Life sciences.

[29]  N. Kandiah,et al.  White Matter Disease Independently Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease in a Clinic Cohort , 2011, Dementia and Geriatric Cognitive Disorders.

[30]  S. Kanba,et al.  Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study , 2011, Hypertension.

[31]  H. Arai,et al.  Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease , 2011, European journal of neurology.

[32]  L. Fratiglioni,et al.  Midlife overweight and obesity increase late-life dementia risk , 2011, Neurology.

[33]  K. Anstey,et al.  Body mass index in midlife and late‐life as a risk factor for dementia: a meta‐analysis of prospective studies , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[34]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[35]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[36]  M. Albert,et al.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[37]  A. Brickman,et al.  Physical activity and Alzheimer disease course. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[38]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[39]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[40]  H. Urbach,et al.  Comment on: Brain Microbleeds and Alzheimer’s Disease: Innocent Observation or Key Player? , 2011, Clinical Neuroradiology.

[41]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[42]  S. Leurgans,et al.  Microinfarct Pathology, Dementia, and Cognitive Systems , 2011, Stroke.

[43]  Minna Rusanen,et al.  Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. , 2011, Archives of internal medicine.

[44]  E. Wijsman,et al.  Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.

[45]  N. Pivac,et al.  Serum lipid levels in patients with Alzheimer's disease. , 2011, Collegium antropologicum.

[46]  J. Geiger,et al.  Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. , 2010, Free radical biology & medicine.

[47]  D. Bennett,et al.  Where Vascular Meets Neurodegenerative Disease , 2010, Stroke.

[48]  H. Soininen,et al.  Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study , 2010, Dementia and Geriatric Cognitive Disorders.

[49]  J. Gilbert,et al.  Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities , 2010, PLoS genetics.

[50]  S. Kanba,et al.  Insulin resistance is associated with the pathology of Alzheimer disease , 2010, Neurology.

[51]  Michael W. Weiner,et al.  Obesity is linked with lower brain volume in 700 AD and MCI patients , 2010, Neurobiology of Aging.

[52]  P. Wolf,et al.  Depressive symptoms and risk of dementia , 2010, Neurology.

[53]  A. Zonderman,et al.  Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment , 2010, Neurology.

[54]  A. Atri,et al.  Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers , 2010, Alzheimer disease and associated disorders.

[55]  A. Işık,et al.  The relationship between body mass index and incidental mild cognitive impairment, Alzheimer’s disease, and Vascular Dementia in elderly , 2010, The journal of nutrition, health & aging.

[56]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[57]  M. H. Walsh,et al.  Actions of adiponectin on the excitability of subfornical organ neurons are altered by food deprivation , 2010, Brain Research.

[58]  K. Welsh-Bohmer,et al.  Occupational exposure to pesticides increases the risk of incident AD , 2010, Neurology.

[59]  Douglas H. Smith,et al.  Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? , 2010, Nature Reviews Neuroscience.

[60]  P. S. St George-Hyslop,et al.  The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease , 2010, International journal of geriatric psychiatry.

[61]  N. Lunet,et al.  Caffeine intake and dementia: systematic review and meta-analysis. , 2010, Journal of Alzheimer's disease : JAD.

[62]  J. Geiger,et al.  Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. , 2010, Journal of Alzheimer's disease : JAD.

[63]  M. Kivipelto,et al.  Caffeine as a protective factor in dementia and Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[64]  K. Ritchie,et al.  Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. , 2010, Journal of Alzheimer's disease : JAD.

[65]  Bryan Maloney,et al.  The “LEARn” (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer’s disease, and proposes remedial steps , 2010, Experimental Gerontology.

[66]  Z. Zuo,et al.  Spine Surgery under General Anesthesia May Not Increase the Risk of Alzheimer’s Disease , 2010, Dementia and Geriatric Cognitive Disorders.

[67]  Ana M. García,et al.  Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[68]  D. Sparks,et al.  Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease , 2010, Neurology.

[69]  Anton P. Porsteinsson,et al.  Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders , 2010, Biological Psychiatry.

[70]  D. Sparks,et al.  Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort , 2010, Neurodegenerative Diseases.

[71]  Filippo Caraci,et al.  Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. , 2010, European journal of pharmacology.

[72]  Sudha Seshadri,et al.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. , 2009, JAMA.

[73]  Zina Kroner,et al.  The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? , 2009, Alternative medicine review : a journal of clinical therapeutic.

[74]  M. Barcikowska,et al.  PIN1 gene variants in Alzheimer's disease , 2009, BMC Medical Genetics.

[75]  M. Taouis,et al.  Adiponectin and energy homeostasis: consensus and controversy. , 2009, The Journal of nutritional biochemistry.

[76]  N. Zawia,et al.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases , 2009, Molecular Psychiatry.

[77]  J. Dartigues,et al.  Leisure activities and the risk of dementia in the elderly , 2009, Neurology.

[78]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[79]  J. Kaprio,et al.  Coffee drinking in middle age is not associated with cognitive performance in old age. , 2009, The American journal of clinical nutrition.

[80]  O. Hanon,et al.  Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease. , 2009, American journal of hypertension.

[81]  Andrew J. Saykin,et al.  Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.

[82]  C. Lendon,et al.  A common biological mechanism in cancer and Alzheimer's disease? , 2009, Current Alzheimer research.

[83]  E. Larson,et al.  Association between late-life body mass index and dementia , 2009, Neurology.

[84]  V. Haroutunian,et al.  Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons , 2009, Neurology.

[85]  A. Hofman,et al.  Duration of antihypertensive drug use and risk of dementia , 2009, Neurology.

[86]  R. Kenny,et al.  Blood pressure and the risk for dementia—A double edged sword , 2009, Ageing Research Reviews.

[87]  B. Winblad,et al.  Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study , 2009, Diabetologia.

[88]  Lewis H Kuller,et al.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study. , 2009, Archives of neurology.

[89]  V. Pankratz,et al.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.

[90]  Eden R Martin,et al.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.

[91]  S E Poduslo,et al.  Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[92]  L. Fratiglioni,et al.  Mid- and Late-Life Diabetes in Relation to the Risk of Dementia , 2009, Diabetes.

[93]  P. Davies,et al.  Therapeutic potential of resveratrol in Alzheimer's disease , 2008, BMC Neuroscience.

[94]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[95]  A Hofman,et al.  Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[96]  Sudha Seshadri,et al.  Association of alcohol consumption with brain volume in the Framingham study. , 2008, Archives of neurology.

[97]  L. Lannfelt,et al.  Impaired insulin secretion increases the risk of Alzheimer disease , 2008, Neurology.

[98]  J. Feldon,et al.  The impact of voluntary exercise on mental health in rodents: A neuroplasticity perspective , 2008, Behavioural Brain Research.

[99]  C. Bulpitt,et al.  Alcohol, dementia and cognitive decline in the elderly: a systematic review. , 2008, Age and ageing.

[100]  V. Pankratz,et al.  Association of duration and severity of diabetes mellitus with mild cognitive impairment. , 2008, Archives of neurology.

[101]  M. Hamer,et al.  Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence , 2008, Psychological Medicine.

[102]  D. Bennett,et al.  Change in depressive symptoms during the prodromal phase of Alzheimer disease. , 2008, Archives of general psychiatry.

[103]  Ana M. García,et al.  Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. , 2008, International journal of epidemiology.

[104]  A. Hofman,et al.  Prestroke Cognitive Performance, Incident Stroke, and Risk of Dementia: The Rotterdam Study , 2008, Stroke.

[105]  D A Bennett,et al.  Relation of cognitive activity to risk of developing Alzheimer disease , 2007, Neurology.

[106]  Kaarin J Anstey,et al.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. , 2007, American journal of epidemiology.

[107]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[108]  C. Tseng,et al.  A case-control study of occupational magnetic field exposure and Alzheimer's disease: results from the California Alzheimer's Disease Diagnosis and Treatment Centers , 2007, BMC neurology.

[109]  Winnie S. Liang,et al.  GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.

[110]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[111]  M. Gill,et al.  Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.

[112]  N. Zawia,et al.  How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. , 2007, Current Alzheimer research.

[113]  A. Murray,et al.  Autonomic dysfunction in dementia , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[114]  Hong Qing,et al.  Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression , 2006, Proceedings of the National Academy of Sciences.

[115]  L. Zacharia,et al.  Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production , 2006, Neuroscience.

[116]  J. Langlois,et al.  Incidence of Traumatic Brain Injury in the United States, 2003 , 2006, The Journal of head trauma rehabilitation.

[117]  A. Seidler,et al.  Occupational exposure to low frequency magnetic fields and dementia: a case–control study , 2006, Occupational and Environmental Medicine.

[118]  Avshalom Caspi,et al.  Gene–environment interactions in psychiatry: joining forces with neuroscience , 2006, Nature Reviews Neuroscience.

[119]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[120]  Lenore J Launer,et al.  Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension , 2006, Stroke.

[121]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[122]  Li Wang,et al.  Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older , 2006, Annals of Internal Medicine.

[123]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[124]  B. Winblad,et al.  Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.

[125]  M. Reger,et al.  Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study , 2005 .

[126]  N. Lautenschlager,et al.  Dementia associated with alcohol and other drug use , 2005, International Psychogeriatrics.

[127]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[128]  A. Hofman,et al.  Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.

[129]  M. M. Mielke,et al.  High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.

[130]  Kristine Yaffe,et al.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study , 2005, BMJ : British Medical Journal.

[131]  Bernd W. Brandt,et al.  Variation in the human TP53 gene affects old age survival and cancer mortality1 , 2005, Experimental Gerontology.

[132]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[133]  B. Winblad,et al.  Occupational Exposure to Electromagnetic Fields and Risk of Alzheimer's Disease , 2004, Epidemiology.

[134]  P. Elias,et al.  Blood Pressure-Related Cognitive Decline: Does Age Make a Difference? , 2004, Hypertension.

[135]  B. Winblad,et al.  Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study , 2004, BMJ : British Medical Journal.

[136]  Freya Kamel,et al.  Association of Pesticide Exposure with Neurologic Dysfunction and Disease , 2004, Environmental health perspectives.

[137]  K. Lu Pinning down cell signaling, cancer and Alzheimer's disease. , 2004, Trends in biochemical sciences.

[138]  N. Pedersen,et al.  How heritable is Alzheimer's disease late in life? Findings from Swedish twins , 2004, Annals of neurology.

[139]  C B Hall,et al.  Low blood pressure and the risk of dementia in very old individuals , 2003, Neurology.

[140]  R. Mayeux,et al.  Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.

[141]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[142]  S Rabe-Hesketh,et al.  Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication , 2003, Journal of neurology, neurosurgery, and psychiatry.

[143]  R. Nussbaum,et al.  Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.

[144]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[145]  J. Dartigues,et al.  Neurodegenerative diseases and exposure to pesticides in the elderly. , 2003, American journal of epidemiology.

[146]  B. Winblad,et al.  Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. , 2002, Journal of clinical epidemiology.

[147]  J. Lindsay,et al.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.

[148]  J. Dichgans,et al.  Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial , 2002, Annals of neurology.

[149]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[150]  E. Jéquier Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.

[151]  C. Cotman,et al.  Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.

[152]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[153]  G. Lenzi,et al.  A case-control study on Alzheimer’s disease and exposure to anesthesia , 2002, Neurological Sciences.

[154]  J. Reif,et al.  Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. , 2002, Scandinavian journal of work, environment & health.

[155]  J. Belleville The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. , 2002, Nutrition.

[156]  Albert Hofman,et al.  Alcohol consumption and risk of dementia: the Rotterdam Study , 2002, The Lancet.

[157]  R. Green,et al.  Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.

[158]  F. Sung,et al.  Risk of Cognitive Impairment in Relation to Elevated Exposure to Electromagnetic Fields , 2002, Journal of occupational and environmental medicine.

[159]  L. Beckett,et al.  Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.

[160]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[161]  J. Manfreda,et al.  Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. , 2001, International journal of epidemiology.

[162]  I. Fortier,et al.  Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study. , 2001, Environmental research.

[163]  D. Power,et al.  Circulating Leptin Levels and Weight Loss in Alzheimer’s Disease Patients , 2001, Dementia and Geriatric Cognitive Disorders.

[164]  J. Guralnik,et al.  Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.

[165]  C. DeCarli,et al.  Head injury and the risk of AD in the MIRAGE study , 2000, Neurology.

[166]  E. Rimm,et al.  Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors , 1999, BMJ.

[167]  Y. Stern,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[168]  F. Gage,et al.  Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus , 1999, Nature Neuroscience.

[169]  T. Olsson,et al.  Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease. , 1998, Biological psychiatry.

[170]  A. Smargiassi,et al.  A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. , 1998, Neurotoxicology.

[171]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[172]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[173]  E. Sobel,et al.  Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer's disease , 1996, Neurology.

[174]  S. Tyas Are tobacco and alcohol use related to Alzheimer's disease? A critical assessment of the evidence and its implications , 1996, Addiction biology.

[175]  J. Kaprio,et al.  Alzheimer's disease in Finnish twins , 1996, The Lancet.

[176]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[177]  E B Larson,et al.  Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. , 1995, American journal of epidemiology.

[178]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[179]  E. Baker A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[180]  G. Belle,et al.  Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study , 1992, Neurology.

[181]  G. Nisticó,et al.  Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. , 1991, Functional neurology.

[182]  P C O'Brien,et al.  Brain injury and neurologic sequelae , 1991, Neurology.

[183]  D. Birkett,et al.  The Relationship between Cancer and Alzheimer's Disease , 1991, Journal of the American Geriatrics Society.

[184]  H. Riihimäki,et al.  Occupational solvent exposure and neuropsychiatric disorders. , 1984, Scandinavian journal of work, environment & health.

[185]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[186]  R. Kimbrough,et al.  The ultrastructure of livers of rats fed DDT and dieldrin. , 1971, Archives of environmental health.

[187]  Stuart Maudsley,et al.  Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer's disease. , 2012, Current Alzheimer research.

[188]  Stuart Maudsley,et al.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. , 2012, Current Alzheimer research.

[189]  D. Loewenstein,et al.  High Blood caffeine levels in MCI linked to lack of progression to dementia. , 2012, Journal of Alzheimer's disease : JAD.

[190]  P. S. St George-Hyslop,et al.  This month in archives of neurology. , 2012, Archives of neurology.

[191]  M. Weiner,et al.  Lipids and adipokines as risk factors for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[192]  M. Avidan,et al.  Review of clinical evidence for persistent cognitive decline or incident dementia attributable to surgery or general anesthesia. , 2011, Journal of Alzheimer's disease : JAD.

[193]  Neil M Davies,et al.  Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. , 2011, Journal of Alzheimer's disease : JAD.

[194]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[195]  L. White,et al.  Coffee intake in midlife and risk of dementia and its neuropathologic correlates. , 2011, Journal of Alzheimer's disease : JAD.

[196]  J. Delgado-García,et al.  Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. , 2011, Journal of Alzheimer's disease : JAD.

[197]  K. Lunetta,et al.  Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. , 2011, Journal of Alzheimer's disease : JAD.

[198]  C. Cao,et al.  Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice. , 2011, Journal of Alzheimer's disease : JAD.

[199]  M. Mena,et al.  Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[200]  S. Glantz,et al.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. , 2010, Journal of Alzheimer's disease : JAD.

[201]  C. Gong,et al.  Anesthetics and tau protein: animal model studies. , 2010, Journal of Alzheimer's disease : JAD.

[202]  V. Finder Alzheimer's disease: a general introduction and pathomechanism. , 2010, Journal of Alzheimer's disease : JAD.

[203]  F. Bilotta,et al.  Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis. , 2010, Journal of Alzheimer's disease : JAD.

[204]  M. Bednar,et al.  Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. , 2010, Journal of Alzheimer's disease : JAD.

[205]  Y. Ikeda,et al.  Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. , 2009, Journal of atherosclerosis and thrombosis.

[206]  H. Soininen,et al.  Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. , 2009, Journal of Alzheimer's disease : JAD.

[207]  L. Chu,et al.  Late-life body mass index and waist circumference in amnestic mild cognitive impairment and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[208]  D. Holtzman,et al.  Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. , 2009, Journal of Alzheimer's disease : JAD.

[209]  Zachary Munn,et al.  Cognitive Leisure Activities and their Role in Preventing Dementia: A Systematic Review , 2009, JBI library of systematic reviews.

[210]  S. Cichon,et al.  Bmc Medical Genomics a Genome-wide Association Study for Late-onset Alzheimer's Disease Using Dna Pooling , 2008 .

[211]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[212]  P. Barberger‐Gateau,et al.  Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. , 2004, The journal of nutrition, health & aging.

[213]  J. Ashford,et al.  Non-familial Alzheimer's disease is mainly due to genetic factors. , 2002, Journal of Alzheimer's disease : JAD.

[214]  P. Lee,et al.  Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.

[215]  Blain Pg Aspects of pesticide toxicology. , 1990 .